$NEXT.E.GO N.V.(EGOX)$
According to our current EGOX stock forecast, the value of Next.e.GO N.V. Ordinary Shares shares will rise by 2.33% and reach $ 0.521876 per share by January 10, 2024. According to our technical indicators, the current sentiment is Neutral while the Fear & Greed Index is showing 39 (Fear). EGOX stock recorded 17/30 (57%) green days with 9.12% price volatility over the last 30 days. Based on our Next.e.GO N.V. Ordinary Shares stock forecast, it's now a good time to buy EGOX stock because it's trading 2.28% below our forecast.
Trade Potentials From 01-Dec Post Market Gainers
@nerdbull1669：I have been monitoring how the stocks are trading in the after hours, and see if there is a chance we can catch any Gap up or potential breakout. In this article, I will be sharing with you on 5 stocks which my self built scanner has identified as potentials, but I narrowed it down to 2 stocks with a significant amount of volume. Allow me to explain why, because if there is considerable interest from investors in after hours on these stocks either due to positive news or events, then this stock would have potential for higher price move in the next trading day. But do remember there could be immediate events or actions which could turn the stock in another way. I shall use technical indicators to help us to see if these 2 stocks $NexImmune, Inc.(NEXI)$ and $Terns Pharmaceuticals, Inc.(TERN)$ would have potential for upside on 04 Dec 2023 trading. NexImmune, Inc (NEXI) NEXI is currently inline with 50 and 200 day moving average, so there is a 50% chance of either upside or downside. On 30 Nov NEXI got notice from listing qualifications, this might explain the surge 01 Dec trading, we will need to monitor and see how price action movement played out. NEXI ADX is closing in at the 40 level, moving into Strong trend, with +DI above -DI by a large margin, I think there is a chance that NEXI could make another upside before trending downwards. If we notice that the 17% increase happened after they furnish information that is required by NASDAQ. From the RSI, it is currently in the overbought territory, which would mean that investors are getting interested in this stock, there might be a chance of increase buying activities. But we need to be aware that investors might think otherwise when a stock is called for listing qualification. Terns Pharmaceuticals, Inc (TERN) TERN has just retake the 50-day moving average, and TERN does not have much news and recently Mizuho cut their target price from $17 to $10. What we need to closely monitor is its candidates whether there is any new development. I hope to see consistent upside from TERN. ADX is below 20 indicating a weak trend, this could be the same reason why Mizuho downgrade its target price, but $10 is still a good level from its current traded price. +DI is above -DI which suggest a promising upside. I will take a look at how the price action played out today (04 Dec). This could give us an indication whether TERN will have a longer upside. RSI is trying to go into overbought territory but it is still not very close, so very much depend on whether there will be a larger volume of buying, as there is only 87k plus volume in after hours last night. Summary Based on the data I have gathered, what is important would be the traders and investors interest and sentiment, as we can see that both of these 2 stocks have almost similar percent change, but the after hours volume is different. I would monitor these 2 stocks for price action, as I believe there is a chance we can trade on small pullback. Appreciate if you could share your thoughts in the comment section whether you think these 2 stocks using after hours statistics would help us to find opportunities to trade. @TigerStars @Daily_Discussion @Tiger_Earnings @TigerWire appreciate if you could feature this article so that fellow tiger would benefit from my investing and trading thoughts. Disclaimer: The analysis and result presented does not recommend or suggest any investing in the said stock. This is purely for Analysis.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
